Close Menu

NEW YORK (GenomeWeb) – NanoString Technologies said today that it has entered into a new $100 million term loan facility with the CR Group (CRG), a health care-focused investment firm.

NanoString will use an aggregate of $60 million in proceeds from an initial draw to refinance its existing CRG term loan facility, under which approximately $50 million is currently outstanding. NanoString will also use proceeds for working capital and general corporate purposes and for transaction-related fees and expenses.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The UK and the European Union have come to a sticking point in the negotiation of how the UK might remain involved in the Horizon Europe research program, the Guardian reports.

The New York Times reports that experts pushed during a meeting of an FDA advisory board for the agency to require more safety data from SARS-CoV-2 vaccine trials.

The Washington Post reports Moderna expects that it will have enough data on its candidate SARS-CoV-2 vaccine to submit to regulatory authorities by mid-November.

In Science this week: ANXA11 variants affect calcium homeostasis and stress granule disassembly in ALS, and more.